Why the study?
New international guidelines introduced updated recommendations for major CV risk factor management, and the COVID-19 pandemic significantly disrupted routine CV prevention and healthy behaviors.
This executive document updates Italian recommendations on cardiovascular prevention, emphasizing lower therapeutic targets, combination therapies, and the critical need to reinforce prevention strategies amidst the COVID-19 pandemic.
No takes yet. Share an insight, caveat, or question.
Updates Italian CV prevention consensus on hypertension, dyslipidemia, and diabetes; extends international guidelines but leaves applicability open pending local validation.
Volpe et al. (2022) conducted a review in Cardiovascular disease. This consensus document provides updated recommendations from the Italian Society of Cardiovascular Prevention on managing cardiovascular risk factors in the context of the COVID-19 pandemic.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: